U.S. Markets closed

Johnson & Johnson (JNJ)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
133.45+0.82 (+0.62%)
At close: 4:00PM EDT

133.45 0.00 (0.00%)
After hours: 6:20PM EDT

People also watch
PGMRKKOPFEXOM
Full screen
Previous Close132.63
Open132.28
Bid133.36 x 300
Ask133.69 x 500
Day's Range132.19 - 133.65
52 Week Range109.32 - 137.08
Volume4,659,963
Avg. Volume5,552,395
Market Cap358.18B
Beta0.64
PE Ratio (TTM)22.43
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield3.36 (2.53%)
Ex-Dividend Date2017-08-25
1y Target EstN/A
Trade prices are not sourced from all markets
  • Record $417M award in lawsuit linking baby powder to cancer
    Associated Press2 hours ago

    Record $417M award in lawsuit linking baby powder to cancer

    A Los Angeles jury on Monday ordered Johnson & Johnson to pay a record $417 million to a hospitalized woman who claimed in a lawsuit that the talc in the company's iconic baby powder causes ovarian cancer ...

  • The Latest: Plaintiff wanted to help others in talc case
    Associated Press3 hours ago

    The Latest: Plaintiff wanted to help others in talc case

    The Latest on a Los Angeles jury ordering Johnson & Johnson to pay $417 million in a case alleging talcum powder causes ovarian cancer (all times local): ___ 12:30 p.m. The attorney for a hospitalized ...

  • Reuters4 hours ago

    J&J ordered to pay $417 mln in trial over talc cancer risks

    A California jury on Monday ordered Johnson & Johnson to pay $417 million to a woman who claimed she developed ovarian cancer after using the company's talc-based products like Johnson's Baby Powder for feminine hygiene. The Los Angeles Superior Court jury's verdict in favor of California resident Eva Echeverria was the largest yet in lawsuits alleging J&J failed to adequately warn consumers about the cancer risks of its talc-based products. "We are grateful for the jury's verdict on this matter and that Eva Echeverria was able to have her day in court," Mark Robinson, her lawyer, said in a statement.